INTERCEPT PHARMACEUTICALS IN shareholder history

Current and past INTERCEPT PHARMACEUTICALS IN shareholders
Period Weighting Quarter
CompanyLongestShortestMin.Avg.Max.FirstLatest↓ Count
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 18180.00%0.00%0.00%Q2 2019Q3 202318
GABELLI & Co INVESTMENT ADVISERS, INC. 18180.02%0.03%0.06%Q2 2019Q3 202318
FRANKLIN RESOURCES INC 18180.01%0.01%0.02%Q2 2019Q3 202318
Calamos Advisors LLC 18180.01%0.02%0.03%Q2 2019Q3 202318
MORGAN STANLEY 14140.00%0.00%0.00%Q2 2019Q3 202214
Context Capital Management, LLC 860.45%1.21%2.54%Q2 2019Q3 202314
FMR LLC 13130.00%0.00%0.00%Q2 2019Q2 202213
PenderFund Capital Management Ltd. 640.98%2.70%4.18%Q3 2020Q3 202310
DEUTSCHE BANK AG\ 770.00%0.00%0.00%Q3 2019Q1 20219
HIGHBRIDGE CAPITAL MANAGEMENT LLC 420.07%1.19%2.38%Q2 2019Q1 20228
WOLVERINE ASSET MANAGEMENT LLC 880.01%0.10%0.25%Q2 2019Q1 20218
LAZARD ASSET MANAGEMENT LLC 880.01%0.02%0.02%Q2 2019Q1 20218
BNP PARIBAS FINANCIAL MARKETS 880.00%0.01%0.01%Q2 2019Q1 20218
CSS LLC/IL 880.03%0.23%0.44%Q2 2019Q1 20218
NOMURA HOLDINGS INC 420.00%0.00%0.02%Q2 2019Q1 20216
Senvest Management, LLC 660.20%0.37%0.51%Q2 2019Q3 20206
Citadel Advisors 550.00%0.01%0.01%Q2 2019Q2 20205
SG Americas Securities, LLC 550.01%0.04%0.07%Q2 2019Q2 20205
Teton Advisors, Inc. 550.03%0.04%0.04%Q3 2019Q3 20205
OAKTREE CAPITAL MANAGEMENT LP 550.05%0.08%0.12%Q3 2022Q3 20235
GABELLI FUNDS LLC 550.02%0.02%0.03%Q3 2019Q3 20205
Russell Investments Group, Ltd. 550.00%0.00%0.00%Q3 2022Q3 20235
BARCLAYS PLC 320.00%0.00%0.00%Q2 2019Q3 20205
LINDEN ADVISORS LP 550.15%0.38%0.48%Q2 2019Q2 20205
AQR Arbitrage LLC 410.05%0.13%0.27%Q2 2019Q3 20235
ADVENT CAPITAL MANAGEMENT /DE/ 440.06%0.24%0.31%Q4 2019Q3 20204
WELLINGTON MANAGEMENT GROUP LLP 440.00%0.00%0.00%Q2 2019Q1 20204
Bank of New York Mellon Corp 440.00%0.00%0.00%Q3 2019Q2 20204
AMERIPRISE FINANCIAL INC 210.00%0.00%0.00%Q2 2019Q2 20214
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 440.13%0.15%0.18%Q2 2021Q1 20224
Polar Asset Management Partners Inc. 220.08%0.18%0.24%Q2 2019Q2 20204
SSI INVESTMENT MANAGEMENT LLC 440.39%0.45%0.53%Q2 2019Q1 20204
BANK OF AMERICA CORP /DE/ 210.00%0.00%0.00%Q3 2019Q4 20204
CREDIT SUISSE AG/ 310.00%0.00%0.01%Q2 2019Q2 20204
Kohlberg Kravis Roberts & Co. L.P. 330.02%0.09%0.14%Q4 2020Q2 20213
NEW YORK STATE COMMON RETIREMENT FUND 330.00%0.00%0.00%Q1 2020Q3 20203
UBS ASSET MANAGEMENT AMERICAS INC 330.00%0.00%0.00%Q1 2023Q3 20233
FIRST HAWAIIAN BANK 330.01%0.01%0.01%Q3 2019Q1 20203
Soros Fund Management 330.33%0.36%0.39%Q3 2020Q1 20213
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 330.07%0.10%0.15%Q4 2019Q2 20203
FARALLON CAPITAL MANAGEMENT LLC 330.15%0.17%0.19%Q4 2019Q2 20203
DLD Asset Management, LP 220.11%0.41%0.70%Q1 2020Q2 20202
Worth Venture Partners, LLC 220.56%1.88%3.20%Q1 2020Q2 20202
Magnetar Financial LLC 220.09%0.09%0.10%Q3 2019Q4 20192
Jefferies Group LLC 220.00%0.00%0.00%Q1 2020Q2 20202
UBS Group AG 220.00%0.00%0.00%Q2 2020Q3 20202
JPMORGAN CHASE & CO 220.00%0.00%0.00%Q1 2020Q2 20202
CAPSTONE INVESTMENT ADVISORS, LLC 220.00%0.00%0.00%Q4 2020Q1 20212
CONTRARIAN CAPITAL MANAGEMENT, L.L.C. 221.58%2.27%2.97%Q1 2021Q2 20212
DG Capital Management, LLC 220.39%0.49%0.59%Q2 2023Q3 20232
Antara Capital LP 220.43%0.64%0.84%Q2 2019Q3 20192
Weiss Asset Management LP 110.09%0.52%0.94%Q4 2020Q3 20232
BOOTHBAY FUND MANAGEMENT, LLC 220.06%0.19%0.32%Q1 2020Q2 20202
Opti Capital Management, LP 220.47%0.81%1.14%Q3 2020Q4 20202
GOLDMAN SACHS GROUP INC 220.00%0.00%0.00%Q2 2019Q3 20192
Graham Capital Management, L.P. 110.31%0.31%0.31%Q2 2019Q2 20191
Eventide Asset Management 110.03%0.03%0.03%Q4 2019Q4 20191
Skaana Management L.P. 110.48%0.48%0.48%Q3 2023Q3 20231
WELLS FARGO & COMPANY/MN 110.00%0.00%0.00%Q2 2019Q2 20191
Allianz Asset Management GmbH 110.01%0.01%0.01%Q2 2019Q2 20191
Context Partners Fund, L.P. 111.12%1.12%1.12%Q3 2020Q3 20201
SYQUANT CAPITAL SAS 110.77%0.77%0.77%Q3 2023Q3 20231
LMR Partners LLP 113.04%3.04%3.04%Q4 2019Q4 20191
SUSQUEHANNA INTERNATIONAL GROUP, LLP 110.00%0.00%0.00%Q3 2019Q3 20191
Shaolin Capital Management LLC 110.29%0.29%0.29%Q4 2020Q4 20201
Anson Funds Management LP 110.79%0.79%0.79%Q3 2023Q3 20231
BlackRock Inc. 110.00%0.00%0.00%Q2 2021Q2 20211
SILVERBACK ASSET MANAGEMENT LLC 110.27%0.27%0.27%Q2 2020Q2 20201

This page lists all the filers that currently own INTERCEPT PHARMACEUTICALS IN or have owned INTERCEPT PHARMACEUTICALS IN in the past.